Why Are Hospitals Treating COVID Patients With a Deadly Drug? Follow The Money, Says Texas Doctor

Dr. Bryan Ardis said the U.S. government is bribing hospitals to prescribe a dangerous drug for patients 65 and over who are suffering from respiratory symptoms diagnosed as brought on by COVID-19.

And he produced the documents from the government's own websites to prove it during a recent interview with Brannon Howse Live.

If you want to know why so many people have died in hospitals from a mostly treatable respiratory illness, all you have to do is follow the money, he said.

"I am talking about the outright criminal use of Remdesivir as a supposed treatment for COVID-19 which has been producing the most deaths from COVID-19 in hospitals," said Ardis, a physician in Dallas, Texas, who has been successfully treating COVID patients since the beginning.

His website is

"I've been warning people for the last year and a half and now I'm warning the world about the current vaccination situation and what they're doing to try to injure, maim and kill as many people as possible with these shots," he told Howse.

Ardis directed Howse to a chart posted July 8, 2021, on the website for the National Institutes of Health, [To find the chart, type the following in a search engine: "Nih.gov table 2E. characteristics of antiviral agents that are approved"]

"What is significant on this chart is that Remdesivir is the first drug listed for treatment of COVID-19, and it causes increased liver enzyme activities showing liver failure," Ardis said.

The drug vehicle for Remdesivir is SBECD, which according to the NIH website, "has been associated with renal and liver toxicity."  Listed side effects are acute kidney failure and liver failure.

The second drug listed is Ivermectin.

"The NIH, CDC, FDA, and World Health Organization tell you that Ivermectin is not approved for COVID treatment and every patient that goes into a hospital is told by a doctor that Ivermectin is not approved," Ardis said. "So when I found this chart showing it has been approved just the same as Remdesivir has been I started sending this out to everyone. It even gives you the doses."

That five-day window of time for Ivermectin dosages and the amounts are exactly the same as America's Frontline Doctors have posted on their website.

"But what do you hear in the media?" Ardis asked.

The media has fixated on one random, unrelated fact, that Ivermectin is also used as a dewormer for horses.

"Just so you know, they are lying to you when they said Ivermectin is not approved," Ardis said.

It is an approved treatment by the NIH.

"What's interesting is you will see actors on TV and media outlets actually saying the CDC does not approve of Ivermectin, the FDA does not approve Ivermectin, the World Health Organization does not approve Ivermectin, but they never say anything about the NIH."

And it's the NIH that has been driving the guidelines for how to treat COVID, not the FDA or CDC.

"Who has set all of the treatment standards for the treatment of COVID from the beginning? Who does Anthony Fauci work for? The NIH. But do you think the NIH has told CNBC, Fox News and all the others that they have approved Ivermectin?" Ardis asked.

No, they have not. They have stayed silent on the matter.

That's why Ardis advises people to print out the chart on the NIH website and present it when they check into any hospital with a COVID diagnosis.

Ardis drilled down on the side effects of the various COVID drugs.

Remdesivir has the following side effect listed on the NIH website: "Drug vehicle is SBECD, which has been associated with renal and liver toxicity. SBECD accumulation may occur in patients with moderate or severe renal impairment."

Ivermectin's first listed comment is "generally well tolerated" with nothing about kidney or liver failure or any other organ failure.

Ardis also showed on the Center for Medicare & Medicaid Services website, CMS.gov, that hospitals prescribing Remdesivir qualify for a 20 percent bonus payout, per patient.

At the 15:31 mark in the interview, Ardis showed a screenshot of the CMS bonus payment. You can find it for yourself by typing "CMS.gov 22 percent bonus payout" into your favorite search engine. The web page states:

"NCTAP claims are those that are eligible for the 20 percent add-on payment under section 3710 of the CARES Act. Eligible claims have both of the following:

  • ICD-10-CM diagnosis U071 [COVID-19]
  • ICD-10-PCS codes for remdesivir [Veklury] COVID-19 convalescent plasma or baricitinib in combination with remdesivir as described below."

So if you want to know why hospitals prefer to treat patients with Remdesivir over Ivermectin, the answer is in the dollar signs. They will make more money treating with Remdesivir.

"Now why would Medicare Services want to bribe them and give a 20 percent added payout for patients 65 and older? I want to know," Ardis said. "Do you think it benefits somebody who can't breathe to shut down their kidneys with a drug that floods their lungs with water; do you think that would make their respiratory issues better or worse?"

"Then you're going to have to vent these people. So that's exactly how the hospital is going to do that. Why would CMS do that?"

Ardis can only speculate on the reason, but the logic is pretty strongly in favor of the numbers.

"I've been reading for the last 20 years that Medicare and Social Security funds, they've been concerned about the Baby Boomer ages, when all these people were going to be turning into their 60s, they were worried about all these people they were going to have to pay out for," he said.

Ivermectin is not the only cheap, effective drug that the government is discouraging the use of in hospitals.

Ardis instructed viewers to type "C19early.com about treatment for Covid" into their favorite search engine. This site is where research studies for treatments around the world get uploaded.

Under "all mortality results," there are a list of medications on the left, and the percentage represents those individuals who are treated with those items that make improvement and reduce mortality.

The first drug listed is Molnupiravir, a new oral drug patented by Merck, which shows that 89 percent of the COVID patients receiving this drug live. It costs $700.

Next is Povidone Iodine for which 88 percent of patients live and it costs only $1.

Povidone Iodine is a nasal spray, and patients also gargle with it once a day using four drops in about 8 ounces of water.  "It works great," Ardis said.

Way down the list is Remdesivir; it costs $3,120 and has a success rate of only 19 percent. That's without the 20 percent add-on from the Center for Medicare and Medicaid Service [CMS].

"Can you explain to me how fiscally responsible this sounds for CMS to actually bribe hospitals to use Remdesivir, which has a 19 percent success rate?" Ardis said. "When I tell you to stay out of hospitals, and avoid the Remdesivir death cocktail, it's because it doesn't work."

Ivermectin has a 55 percent success rate and costs $1 vs. Remdesivir at $3,120 and 19 percent.

Your Tax Deductible Support at www.wvwfoundation.com Helps Us Cover Our Huge Streaming Bill So You and Millions of Americans Can Watch Our TV Shows For Free. Many organizations put all their shows behind a pay-wall immediately but we make our shows available for all to watch as a public and educational service of WVW-TV and WVW Foundation. You can also use our mailing address to send your tax deductible support:

WVW Foundation
P.O. Box 1690
Collierville, TN 38027



Topic Tags

We're a 100% Listener Supported Network